版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
LSD2014Reviewand2015MarketingPlanStephenZhangG.China:25unitsin75daysWW:120unitsin75days20%LSD2014KeyProductsPerformanceKeyProduct201220132014Growth%GrowthPriorYear
ChemiTouch002525N/AMP55831001720.5%XRS+230178177-1-0.6%GelDocEZ79808556.3%XR+461424363-61-14.4%LSD2014PerformanceandPriorYearOverview2012FullYearActualSales2012FullYearPlan%AchieveRatePriorYearTotal2011%GrowthPriorYear22,84225,78889%23,280(2%)LSDConsumableLSDTotal(kUS$)2012DG:~800kUS$KeyProductLineAnalysisLSDKeyProductline(8.1%)(23.8%)(-520kUS$)5.5%6.4%GE2D:~(-30%)2014FX+SpotCutter:680kUS$LSDPerformancebyDistributor/RegionRegionDistributorLSDRevenueGrowthRateContribution20132014East1BaoCheng
2,229
2,165-3%9.9%East2Shanghai
2,564
2,313-10%10.6%RunYa
1,832
1,9728%9.0%Central&WestBioLegend
1,274
1,3566%6.2%Bio-Bri
1,623
1,89016%8.6%SouthHaoYang
2,662
2,184-18%10.0%North1BaiRuiDe
913
1,08219%4.9%Huili
1,147
1,1480%5.2%DingYong
685
87327%4.0%North2YouHope
2,181
2,1840%10.0%TengLing
883
772-13%3.5%DirectSalesSolution
977
1,40043%6.4%BioPharma
460
59529%2.7%HongKong
687
86526%3.9%
TaiWan
1,535
1,110-28%5.1%KeyInstrumentsbyDistributor/RegionRegionDistributorGelDocXR+GelDocContributionGelDocXRS+ChemiDocMPCDTouchChemiDocContribution201320142014201320142013201420152014East1BaoCheng444312.1%20168628.3%East2Shanghai39339.3%157181327.6%RunYa31215.9%313234213.2%Central&WestBioLegend37185.1%16182317.6%Bio-Bri32246.8%201071058.7%SouthHaoYang544512.7%121915338.7%North1BaiRuiDe18123.4%1276414.2%Huili23257.0%1083324.5%DingYong15174.8%753503.5%North2YouHope57236.5%1822817214.2%TengLing17205.6%545925.2%DirectSalesSolution467019.7%3113706.3%BioPharma120.6%306401.4%HongKong610.3%200712.8%
TaiWan810.3%771403.8%KeyConsumableAnalysisLSDKeyConsumable2.6%(10.6%)US$0.4%(23.9%)(48.2%)ConsumablePerformancebyDistributor/RegionRegionDistributorLSDConsumableGrowthRateContribution-ConsumableContribution-Hardware20132014East1BaoCheng
290,921
281,816-3%11.2%9.5%East2Shanghai
320,392
228,758-29%9.1%10.5%RunYa
239,915
195,039-19%7.7%8.9%Central&WestBioLegend
79,255
99,79626%4.0%6.3%Bio-Bri
98,736
126,41328%5.0%8.9%SouthHaoYang
256,857
311,98621%12.3%9.4%NorthWoEn
449,684
396,967-12%15.7%31.2%DirectSalesSolution
22,577
38,00768%1.5%6.8%BioPharma
100,042
126,48326%5.0%2.4%HongKong
298,486
322,2218%12.8%2.7%
TaiWan
487,718
398,715-18%15.8%3.6%ImagingSystemMarketingDynamicTotal8.8MUS$,FlatTotal16.6MUS$,GrowthRate~5%GelImagingSystemCompetitionLandscapePricePerformance&EasyofuseLocalBrands5kUS$10kUS$GelDocEZRepackingandPricingKUS$DifferentiationGelDocProductsbyStain-freeTechnologyStain-freetechnologypromotioninacademicmarketsegmenttodifferentiateXR+andEZfromcompetitorsStain-freetechnologyeducationtosalesteamandcustomersBundlingsaleswithelectrophoresisandChemisystemConvertbiopharmaceuticalGelDocpotentialstoGS900systemandBiologicsWorkflowtoavoidcompetitionHigherresolution,QuantitationIQ/OQ,32CRFcomplianceCompetewithlocalbrandsandsellGelDocEZ(w/oSF)tolowbudgetcustomersFlexibleconfigureandflexiblepriceEasytouseConcept“separatelyimagingandcuttinggel”ChemiImagingSystemCompetitionLandscape
SensitivityEase-of-UseLAS500ChemiDocXRS+/MPCDTouchLAS&AI600
FilmChemiImagingSystemCompetitorsCompetitorCompanyAttributesProductAttributesPriceGECompanybrandnameisconsideredashightechnologyConvertingfromdirectsalestodistributionSuperCCDandsuperLensRealbestperformance$29,000$32,000$45,000SyngeneGenecompanysalesnetworkFastactiontomarketwithnewspecificationsHighspecification,bothresolutionandsensitivityWhenweupdatetheproduct,Syngeneisthefastestfollower$15,000~$35,000Alpha/UVP/Vilber/AzureFocusonImagingmarketFlexiblesaleschannelsHighresolutionorotherapplicationsLowerpricewhenbiddingMuchlowerthanBio-Rad(morethan30%)DifferentiationwithCompetitorsbyV3WorkflowandTPNTechnologyV3workflowpromotionContinuelabbylabV3&TPNmini-seminarstoeducatecustomersandbuildbrandimageCombineonlinewithonsiteseminartomaximizeaudienceEnhancecustomerexperiencebyroutineV3university(monthlyinBeiJingandShanghaioroutsite)V3promotionthroughwebsiteandpublicityplatform(WeChat)PenetrateV3workflowadoptionCollaborationwithkeyopinionleaderstobreakthroughV3workflowadoptionandbuildV3referencelabsSpecialconsumablesupplypolicytoencouragekeyaccountstoadoptworkflowconsumablesHighprioritytechnicalsupporttoV3workflowuserstoensurevalueidentitybykeyaccounts
LeverageChemiImagingSystembyV3Promotion
BuildLeadershipbyCDTouchValueIdentityand
EncourageSalesTeamtoGraspMarketShareExtensivedemocampaignandtacticallytargetingtoGEandfilmcustomerrealizehighperformancefeatureTrackingalldemotoensuregoodperformanceanduserexperienceFocusonconvertingKOLsfromGEandfilmtoinfluenceotherpotentialsContinuouslykeepsalesenthusiasmbysharingsuccessfulstoryandcompetitiondataHighprioritysettingforsalesteamNolosttoGETechnicalsupportpriority
DemoCampaignChainDistributorFAS/SalesBio-RadFAS/SalesBio-RadSalesManager/MarketingPlanningTrackingExecutingBio-RadCustomerFeedbackHelpCommunicationBestPlanningandExecutingKeyProductBreakthroughtoDriveBrandPenetrationKeyproductbreackthroughDualColorStandardaggressivepricingstrategytodrivebrandpenetrationandleverageallconsumables(~20%lowerthanFermentas)Bio-Rad,5%LT,15%Handcast,80%Bio-Rad,5%Fermentas,75%LocalBrand,20%Millipore,10%Agarose,60%Bio-Rad,0%LT,30%Bio-Rad,15%GE,10%Millipore,75%Bio-Rad,10%Thermo,30%LocalBrand&Others,25%Millipore,35%IPkit GelMarkerMembraneSubstratePricePerformanceConviencePriceConviencePricePerformancePricePerformancePriceKPDIncreaseElectro-WesternConsumableAwarenessTotalelectro-westernconsumablesolutionpromotionEffectiveTools(consumablebrochure)andpromotionFocusonkeyproductstoincreasemarketshareandformuserhabbitSurebeadsProteinStandardValidatedwesternblotantibodiesContinuetheprecastandfastcastgelpricetestingandfollowedbyproperpricingadjust
AgendaSureBeadsandPrecisionAb™antibodiesSampletrialcampaigntoconvertpotentialsLeverageInvitrogenbeadsusersconvertingbybetterperformanceandlowerpriceMaximizePrecisionAbantibodiestrialcampaigncoveragebymulti-channelpromotionAdsandeblastcampaignProductpromotionandintroductionthroughSocialMediatomaximizeaudienceBreakthoughinkeyaccountlabsforquickrevenuerealizationandreferenceinfluenceBundlingsaleswithChemiimagersforquickbreakthough
WeChatPlatformofCRM
DirectcommunicationwithcustomerTimelyresponseandsupporttocustomerCustomerdatabasePushproductinformationAllbasedonadynamic,effective,attractive,interactivemodelCustomerBio-RadDirectCommunicationwithCustomerCustomerAdvantages:CustomerdatabaseCasetrackingBio-RadprofessionalsupportIT-picture,video,hyperlinkProductpromotionCallCen
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024年陕西省渭南市公开招聘警务辅助人员辅警笔试自考题2卷含答案
- 2021年河南省周口市公开招聘警务辅助人员辅警笔试自考题2卷含答案
- 2023年广东省清远市公开招聘警务辅助人员辅警笔试自考题2卷含答案
- 2024年广东省梅州市公开招聘警务辅助人员辅警笔试自考题2卷含答案
- 《新农村户型图》课件
- 2024版建筑劳务分包协议标准文本精简版版B版
- 2024消防安全隐患排查与整改合作协议3篇
- 2024版公租房租赁合同标准样本
- 2024版全新包车客运合同范本下载
- 2024年电子产品一次性销售协议版B版
- 水利水电工程安全管理制度例文(三篇)
- 2025四川宜宾市南溪区属国企业招聘融资人员6人管理单位笔试遴选500模拟题附带答案详解
- DB45T 2048-2019 微型消防站建设管理规范
- 2025年超星尔雅学习通《劳动通论》章节测试题库及参考答案(培优)
- SCTP大云云计算PT2题库【深信服】认证考试题库及答案
- 外研版(2024新版)七年级上册英语期末质量监测试卷 3套(含答案)
- 《测土配方施肥》课件
- 新疆乌鲁木齐市(2024年-2025年小学六年级语文)统编版质量测试(上学期)试卷及答案
- 人教版2024-2025学年第一学期八年级物理期末综合复习练习卷(含答案)
- 职业健康检查管理制度
- 电梯维保管理体系手册
评论
0/150
提交评论